Physician profile
Irene Arroyo
NPI 1083053565
$10,821.10
in general payments reported to CMS, 2019-2025
21 companies · $1,548 in 2025
The $1,548 reported for 2025 was more than what 91% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $1,831 · 2021: $1,765 · 2022: $3,837 · 2023: $147 · 2024: $546 · 2025: $1,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,703 · Travel and Lodging: $509 · Education: $28.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,702.85 |
| Travel and Lodging | $509.43 |
| Education | $28.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $7,732.04 | 2019-2025 | |
| Endo USA, INC. | $652.62 | 2025 | |
| Medline Industries Lp | $377.88 | 2025 | |
| Stryker Corporation | $338.07 | 2020-2024 | Augment Injectable, Anchorage, Ortholoc 2 Lapifuse |
| Smith+Nephew, INC. | $265.02 | 2019-2025 | Grafix Pl, Q-Fix, Digifuse Cannulated Intramedullary Fusion System |
| Integra Lifesciences Corporation | $258.45 | 2021 | |
| Medtronic, INC. | $187.75 | 2022-2024 | Intellis Adaptivestim |
| Kerecis Limited | $162.28 | 2021 | |
| Osteoremedies, LLC | $152.61 | 2025 | Xperience, Blastx |
| Bone Support INC. | $149.66 | 2024 | Ceramentbone Void Filler, Cerament G |
| Polynovo North America LLC | $128.66 | 2025 | Novosorb Btm |
| Vertex Pharmaceuticals Incorporated | $124.91 | 2025 | |
| Depuy Synthes Sales INC. | $69.44 | 2022 | |
| Orthofix Medical, INC. | $42.89 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $41.85 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $32.52 | 2024 | |
| Organogenesis INC. | $26.88 | 2023 | Puraply |
| Extremity Medical | $22.61 | 2021 | |
| Nevro Corp. | $20.81 | 2024 | Senza |
| Musculoskeletal Transplant Foundation INC. | $17.91 | 2023 | |
| Globus Medical, INC. | $16.24 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irene Arroyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.